 Plasmacytoma
"Plasmacytoma" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Any discrete, presumably solitary, mass of neoplastic PLASMA CELLS either in BONE MARROW or various extramedullary sites.
| Descriptor ID |
D010954
|
| MeSH Number(s) |
C04.557.595.600 C20.683.515.880
|
| Concept/Terms |
Plasmacytoma- Plasmacytoma
- Plasmacytomas
- Plasmocytoma
- Plasmocytomas
- Plasma Cell Tumor
- Plasma Cell Tumors
- Tumor, Plasma Cell
- Tumors, Plasma Cell
|
Below are MeSH descriptors whose meaning is more general than "Plasmacytoma".
Below are MeSH descriptors whose meaning is more specific than "Plasmacytoma".
This graph shows the total number of publications written about "Plasmacytoma" by people in this website by year, and whether "Plasmacytoma" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1980 | 0 | 3 | 3 | | 1981 | 0 | 3 | 3 | | 1982 | 0 | 1 | 1 | | 1983 | 1 | 0 | 1 | | 1984 | 0 | 2 | 2 | | 1986 | 0 | 2 | 2 | | 1987 | 0 | 2 | 2 | | 1989 | 0 | 2 | 2 | | 1990 | 1 | 0 | 1 | | 1999 | 1 | 0 | 1 | | 2006 | 2 | 0 | 2 | | 2008 | 1 | 0 | 1 | | 2010 | 0 | 1 | 1 | | 2016 | 1 | 0 | 1 | | 2020 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Plasmacytoma" by people in Profiles.
-
Ellington TD, Henley SJ, Wilson RJ, Wu M, Richardson LC. Trends in solitary plasmacytoma, extramedullary plasmacytoma, and plasma cell myeloma incidence and myeloma mortality by racial-ethnic group, United States 2003-2016. Cancer Med. 2021 01; 10(1):386-395.
-
Deotare U, Yee KW, Le LW, Porwit A, Tierens A, Musani R, Barth D, Torlakovic E, Schimmer A, Schuh AC, Seftel M, Minden MD, Gupta V, Hyjek E. Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: 10-Color flow cytometry diagnosis and HyperCVAD therapy. Am J Hematol. 2016 Mar; 91(3):283-6.
-
Ginat DT, Puri S. FDG PET/CT manifestations of hematopoietic malignancies of the breast. Acad Radiol. 2010 Aug; 17(8):1026-30.
-
Murillo O, Arina A, Hervas-Stubbs S, Gupta A, McCluskey B, Dubrot J, Palazón A, Azpilikueta A, Ochoa MC, Alfaro C, Solano S, Pérez-Gracia JL, Oyajobi BO, Melero I. Therapeutic antitumor efficacy of anti-CD137 agonistic monoclonal antibody in mouse models of myeloma. Clin Cancer Res. 2008 Nov 01; 14(21):6895-906.
-
Liu W, Lacouture ME, Jiang J, Kraus M, Dickstein J, Soltani K, Shea CR. KSHV/HHV8-associated primary cutaneous plasmablastic lymphoma in a patient with Castleman's disease and Kaposi's sarcoma. J Cutan Pathol. 2006 Sep; 33 Suppl 2:46-51.
-
Sinnott BP, Hatipoglu B, Sarne DH. Intrasellar plasmacytoma presenting as a non-functional invasive pituitary macro-adenoma: case report & literature review. Pituitary. 2006; 9(1):65-72.
-
Jones D, Bhatia VK, Krausz T, Pinkus GS. Crystal-storing histiocytosis: a disorder occurring in plasmacytic tumors expressing immunoglobulin kappa light chain. Hum Pathol. 1999 Dec; 30(12):1441-8.
-
Sokolova IA, Volgin AU, Makarova NV, Volgina VV, Shishkin SS, Khodarev NN. Internucleosomal chromatin degradation in myeloma and B-hybridoma cell cultures. FEBS Lett. 1992 Nov 30; 313(3):295-9.
-
Schemankewitz E, Hammami A, Stahl R, Henderson JM, Check IJ. Multiple extramedullary plasmacytomas following orthotopic liver transplantation in a patient on cyclosporine therapy. Transplantation. 1990 May; 49(5):1019-22.
-
Xu M, Hammer RE, Blasquez VC, Jones SL, Garrard WT. Immunoglobulin kappa gene expression after stable integration. II. Role of the intronic MAR and enhancer in transgenic mice. J Biol Chem. 1989 Dec 15; 264(35):21190-5.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|